Literature DB >> 8037211

Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.

H Caron1, P van Sluis, N van Roy, J de Kraker, F Speleman, P A Voûte, A Westerveld, R Slater, R Versteeg.   

Abstract

Neuroblastomas often show loss of heterozygosity of the chromosomal region 1p36 (LOH 1p), probably reflecting loss of a tumor-suppressor gene. Here we describe three neuroblastoma tumors and two cell lines in which LOH 1p results from an unbalanced translocation between the p arm of chromosome 1 and the q arm of chromosome 17. Southern blot and cytogenetic analyses show that in all cases the chromosome 17 homologue from which the 1;17 translocation was derived is still present and intact. This suggests a model in which a translocation between the short arm of chromosome 1 and the long arm of chromosome 17 takes place in the S/G2 phase of the cell cycle and results in LOH 1p. Nonhomologous mitotic recombination in the S/G2 phase is a novel mechanism of LOH.

Entities:  

Mesh:

Year:  1994        PMID: 8037211      PMCID: PMC1918374     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.

Authors:  Y Hayashi; N Kanda; T Inaba; R Hanada; N Nagahara; H Muchi; K Yamamoto
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

2.  Mitotic recombination is responsible for the loss of heterozygosity in cultured murine cell lines.

Authors:  F K Nelson; W Frankel; T V Rajan
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  Definition of a continuous human cell line derived from neuroblastoma.

Authors:  J J Tumilowicz; W W Nichols; J J Cholon; A E Greene
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

4.  Mapping replicational sites in the eucaryotic cell nucleus.

Authors:  H Nakayasu; R Berezney
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

5.  High-resolution fluorescence mapping of 46 DNA markers to the short arm of human chromosome 1.

Authors:  N Van Roy; G Laureys; R Versteeg; G Opdenakker; F Speleman
Journal:  Genomics       Date:  1993-10       Impact factor: 5.736

6.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

7.  Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.

Authors:  M Mannens; R M Slater; C Heyting; J Bliek; J de Kraker; N Coad; P de Pagter-Holthuizen; P L Pearson
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

8.  Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours.

Authors:  E R Fearon; B Vogelstein; A P Feinberg
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

9.  Chromosome analysis of human neuroblastoma cell line TR14 showing double minutes and an aberration involving chromosome 1.

Authors:  J K Cowell; H T Rupniak
Journal:  Cancer Genet Cytogenet       Date:  1983-07

10.  Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.

Authors:  H Christiansen; F Lampert
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

View more
  10 in total

Review 1.  [Neuroblastoma].

Authors:  Victoria Castel; Adela Cañete; Rosa Noguera; Samuel Navarro; Silvestre Oltra
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

2.  Search for neuroblastoma loci: characterization of tumor cell lines that could facilitate their positional cloning.

Authors:  M Romani; R Muresu; E V Volpi; C Rozzo; J M Marchi; I Casciano
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 3.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  Escape from het-6 incompatibility in Neurospora crassa partial diploids involves preferential deletion within the ectopic segment.

Authors:  M L Smith; C J Yang; R L Metzenberg; N L Glass
Journal:  Genetics       Date:  1996-10       Impact factor: 4.562

5.  No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma.

Authors:  R M Hofstra; N C Cheng; C Hansen; R P Stulp; T Stelwagen; N Clausen; N Tommerup; H Caron; A Westerveld; R Versteeg; C H Buys
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

6.  Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.

Authors:  H Caron; P van Sluis; R Buschman; R Pereira do Tanque; P Maes; L Beks; J de Kraker; P A Voûte; G Vergnaud; A Westerveld; R Slater; R Versteeg
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

7.  A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

Authors:  P S White; J M Maris; C Beltinger; E Sulman; H N Marshall; M Fujimori; B A Kaufman; J A Biegel; C Allen; C Hilliard; M B Valentine; A T Look; H Enomoto; S Sakiyama; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

8.  Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

Authors:  F Abel; K Ejeskär; P Kogner; T Martinsson
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

9.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

Review 10.  Molecular biology of neuroblastoma.

Authors:  V Castel; E Grau; R Noguera; F Martínez
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.340

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.